Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Gastrointestinal 1

Conditions

Unspecified Adult Solid Tumor, Protocol Specific 12Leukemia, Myeloid, Acute 11Precursor Cell Lymphoblastic Leukemia-Lymphoma 6Lymphoma, Mantle-Cell 6Leukemia, Lymphocytic, Chronic, B-Cell 6Congenital Abnormalities 6Leukemia, Myelomonocytic, Acute 5Leukemia, Monocytic, Acute 5Leukemia, Erythroblastic, Acute 5Lymphoma, Large B-Cell, Diffuse 4Lymphoma, Follicular 4Lymphoma 4Leukemia, Megakaryoblastic, Acute 4Waldenstrom Macroglobulinemia 3Prostatic Neoplasms 3Lymphoma, Non-Hodgkin 3Lymphoma, B-Cell, Marginal Zone 3Burkitt Lymphoma 3Sarcoma 2Pancreatic Neoplasms 2Neoplasms 2Multiple Myeloma 2Melanoma 2Lymphoma, Large-Cell, Immunoblastic 2Breast Neoplasms 2Blast Crisis 2Wilms Tumor 1Tumor Lysis Syndrome 1Thromboembolism 1Thrombocytopenia 1

Interventions

Imatinib Mesylate 41Sunitinib 17nilotinib 12regorafenib 10ripretinib 6avapritinib 6Leucovorin 3Ipilimumab 3Gemcitabine 3Dasatinib 3CTLA-4 Antigen 34-amino-5-fluoro-3-(5-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl)quinolin-2(1H)-one 3pexidartinib 2Paclitaxel 2Oxaliplatin 2Midazolam 2Irinotecan 2Fluorouracil 2Floxuridine 2Erlotinib Hydrochloride 2Docetaxel 2Cisplatin 2Carboplatin 2Capecitabine 2Biopsy, Fine-Needle 2Bevacizumab 2vatalanib 1umbralisib 1trametinib 1tinostamustine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Gastrointestinal Stromal Tumors × alvocidib × Clear all
NCT00098579 2013-03-19

Doxorubicin Hydrochloride and Alvocidib in Treating Patients With Metastatic or Recurrent Sarcoma That Cannot Be Removed By Surgery

National Cancer Institute (NCI)

Phase 1 Completed
36 enrolled
GastrointestinalSarcoma

Sarcoma, Gastrointestinal Stromal Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡